Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Avenue, Box 0538, San Francisco, CA, 94143, USA.
Department of Pathology, University of California, San Francisco, CA, USA.
Dig Dis Sci. 2022 Jul;67(7):3436-3444. doi: 10.1007/s10620-021-07099-8. Epub 2021 Jun 16.
Accumulation of visceral adipose tissue is associated with hepatic inflammation and fibrosis, suggestive of its metabolic and inflammatory properties. We aimed to examine the histologic findings of visceral and subcutaneous adipose tissue and to associate these findings with clinical and radiologic characteristics in patients with cirrhosis.
Included were 55 adults with cirrhosis who underwent liver transplantation from 3/2017-12/2018 and had an abdominal computed tomography (CT) scan within 6 months prior to transplant. Visceral-to-subcutaneous adipose tissue ratio (VSR) was calculated using visceral (VATI) and subcutaneous adipose tissue index (SATI) quantified by CT at the L3-vertebral level and normalized for height (cm/m). VAT (greater omentum), SAT (abdominal wall), and skeletal muscle (rectus abdominis) biopsies were collected at transplant.
Majority of patients had VAT inflammation (71%); only one patient (2%) had SAT inflammation. Patients with VAT inflammation had similar median VATI (42 vs 41 cm/m), lower median SATI (64 vs 97 cm/m), and higher median VSR (0.63 vs 0.37, p = 0.002) than patients without inflammation. In univariable logistic regression, VSR was associated with VAT inflammation (OR 1.47, 95%CI 1.11-1.96); this association remained significant even after adjusting for age, sex, BMI, HCC, or MELD-Na on bivariable analyses.
In patients with cirrhosis undergoing liver transplantation, histologic VAT inflammation was common, but SAT inflammation was not. Increased VSR was independently associated with VAT inflammation. Given the emerging data demonstrating the prognostic value of VSR, our findings support the value of CT-quantified VSR as a prognostic marker for adverse outcomes in the liver transplant setting.
内脏脂肪组织的堆积与肝脏炎症和纤维化有关,提示其具有代谢和炎症特性。我们旨在检查肝硬化患者的内脏和皮下脂肪组织的组织学发现,并将这些发现与临床和影像学特征相关联。
纳入了 2017 年 3 月至 2018 年 12 月期间进行肝移植的 55 名成年人,并且在移植前 6 个月内进行了腹部计算机断层扫描 (CT) 扫描。使用 CT 在 L3 椎骨水平量化的内脏 (VATI) 和皮下脂肪组织指数 (SATI) 计算内脏到皮下脂肪组织比率 (VSR),并按身高 (cm/m) 进行归一化。在移植时采集了 VAT(大网膜)、SAT(腹壁)和骨骼肌(腹直肌)活检。
大多数患者存在 VAT 炎症(71%);仅有 1 名患者(2%)存在 SAT 炎症。有 VAT 炎症的患者具有相似的中位数 VATI(42 vs 41 cm/m)、较低的中位数 SATI(64 vs 97 cm/m)和较高的中位数 VSR(0.63 vs 0.37,p=0.002)。在单变量逻辑回归中,VSR 与 VAT 炎症相关(OR 1.47,95%CI 1.11-1.96);即使在对双变量分析中的年龄、性别、BMI、HCC 或 MELD-Na 进行调整后,这种关联仍然显著。
在接受肝移植的肝硬化患者中,组织学上的 VAT 炎症很常见,但 SAT 炎症并不常见。增加的 VSR 与 VAT 炎症独立相关。鉴于越来越多的数据表明 VSR 的预后价值,我们的发现支持 CT 量化的 VSR 作为肝移植环境中不良结局的预后标志物的价值。